Replimune (REPL) Income towards Parent Company (2017 - 2026)
Replimune (REPL) recorded Income towards Parent Company of -$69.8 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$86.7 million a year earlier.
Powered by 
Analysis
Replimune (REPL) Income towards Parent Company (2017 - 2026) Analysis & Trends
On a TTM basis, Replimune's Income towards Parent Company came in at -$297.05 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$313.94 million.
- Across earlier fiscal years, Income towards Parent Company came in at -$247.3 million in FY2025, -$215.8 million in FY2024, -$174.3 million in FY2023 and -$118.04 million in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly Income towards Parent Company since fiscal Q3 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$73.22 million (Q4 2026), -$70.93 million (Q3 2026) and -$83.1 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Replimune | 1.10 Bn | 1.10 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.80 Mn |
| Mar 31, 2026 | -73.22 Mn |
| Dec 31, 2025 | -70.93 Mn |
| Sep 30, 2025 | -83.10 Mn |
| Jun 30, 2025 | -86.70 Mn |
| Mar 31, 2025 | -74.10 Mn |
| Dec 31, 2024 | -66.34 Mn |
| Sep 30, 2024 | -53.06 Mn |
| Jun 30, 2024 | -53.77 Mn |
| Mar 31, 2024 | -55.08 Mn |
| Dec 31, 2023 | -51.12 Mn |
| Sep 30, 2023 | -60.04 Mn |
| Jun 30, 2023 | -49.56 Mn |
| Mar 31, 2023 | -49.26 Mn |
| Dec 31, 2022 | -39.70 Mn |
| Sep 30, 2022 | -43.10 Mn |
| Jun 30, 2022 | -42.25 Mn |
| Mar 31, 2022 | -31.70 Mn |
| Dec 31, 2021 | -29.70 Mn |
| Sep 30, 2021 | -29.36 Mn |
API Access
Replimune Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();